_version_ 1785091236120494080
author Ludwig, Heinz
Melchardt, Thomas
Sormann, Siegfried
Schreder, Martin
Andel, Johannes
Hartmann, Bernd
Tinchon, Christoph
Zojer, Niklas
Gunsilius, Eberhard
Podar, Klaus
Egle, Alexander
Willenbacher, Wolfgang
Woell, Ewald
Ruckser, Reinhard
Bozic, Boris
Theresa Krauth, Maria
Petzer, Andreas
Schmitt, Clemens A.
Machherndl-Spandl, Sigrid
Agis, Hermine
Fillitz, Michael
Wang, Song-Yau
Knop, Stefan
Paiva, Bruno
Greil, Richard
author_facet Ludwig, Heinz
Melchardt, Thomas
Sormann, Siegfried
Schreder, Martin
Andel, Johannes
Hartmann, Bernd
Tinchon, Christoph
Zojer, Niklas
Gunsilius, Eberhard
Podar, Klaus
Egle, Alexander
Willenbacher, Wolfgang
Woell, Ewald
Ruckser, Reinhard
Bozic, Boris
Theresa Krauth, Maria
Petzer, Andreas
Schmitt, Clemens A.
Machherndl-Spandl, Sigrid
Agis, Hermine
Fillitz, Michael
Wang, Song-Yau
Knop, Stefan
Paiva, Bruno
Greil, Richard
author_sort Ludwig, Heinz
collection PubMed
description
format Online
Article
Text
id pubmed-10431585
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104315852023-08-17 P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02) Ludwig, Heinz Melchardt, Thomas Sormann, Siegfried Schreder, Martin Andel, Johannes Hartmann, Bernd Tinchon, Christoph Zojer, Niklas Gunsilius, Eberhard Podar, Klaus Egle, Alexander Willenbacher, Wolfgang Woell, Ewald Ruckser, Reinhard Bozic, Boris Theresa Krauth, Maria Petzer, Andreas Schmitt, Clemens A. Machherndl-Spandl, Sigrid Agis, Hermine Fillitz, Michael Wang, Song-Yau Knop, Stefan Paiva, Bruno Greil, Richard Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431585/ http://dx.doi.org/10.1097/01.HS9.0000970676.55498.d5 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Ludwig, Heinz
Melchardt, Thomas
Sormann, Siegfried
Schreder, Martin
Andel, Johannes
Hartmann, Bernd
Tinchon, Christoph
Zojer, Niklas
Gunsilius, Eberhard
Podar, Klaus
Egle, Alexander
Willenbacher, Wolfgang
Woell, Ewald
Ruckser, Reinhard
Bozic, Boris
Theresa Krauth, Maria
Petzer, Andreas
Schmitt, Clemens A.
Machherndl-Spandl, Sigrid
Agis, Hermine
Fillitz, Michael
Wang, Song-Yau
Knop, Stefan
Paiva, Bruno
Greil, Richard
P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02)
title P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02)
title_full P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02)
title_fullStr P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02)
title_full_unstemmed P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02)
title_short P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02)
title_sort p943: outcome analysis by cytogenetic risk group after randomization to krd or ktd followed by k maintenance or control in patients with nte ndmm (agmt mm-02)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431585/
http://dx.doi.org/10.1097/01.HS9.0000970676.55498.d5
work_keys_str_mv AT ludwigheinz p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT melchardtthomas p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT sormannsiegfried p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT schredermartin p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT andeljohannes p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT hartmannbernd p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT tinchonchristoph p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT zojerniklas p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT gunsiliuseberhard p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT podarklaus p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT eglealexander p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT willenbacherwolfgang p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT woellewald p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT ruckserreinhard p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT bozicboris p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT theresakrauthmaria p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT petzerandreas p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT schmittclemensa p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT machherndlspandlsigrid p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT agishermine p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT fillitzmichael p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT wangsongyau p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT knopstefan p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT paivabruno p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02
AT greilrichard p943outcomeanalysisbycytogeneticriskgroupafterrandomizationtokrdorktdfollowedbykmaintenanceorcontrolinpatientswithntendmmagmtmm02